1 The EIC Accelerator Project
EIC Accelerator Program Overview
The EIC Accelerator program is a key initiative under the European Innovation Council (EIC), aimed at supporting innovative startups and SMEs in the European Union. It focuses on high-risk, high-potential companies, particularly those involved in DeepTech sectors, which include advanced manufacturing, life sciences, energy, and information and communication technologies. The program's primary goal is to foster innovation by providing funding and resources that enable these companies to scale their operations, bring their groundbreaking technologies to market, and ultimately contribute to the European economy.
Funding Structure of the EIC Accelerator
The EIC Accelerator offers funding in two primary forms: grants and equity investments.
Role of the EIC Accelerator
The EIC Accelerator plays a crucial role in helping companies scale and secure funding from private sectors. By offering substantial financial support and guidance, the program enhances the viability of startups and SMEs, particularly in the challenging early stages of development. The EIC also provides access to a broad network of investors, mentors, and partners, facilitating connections that can lead to additional funding opportunities and strategic alliances. This comprehensive support system is vital for fostering innovation and ensuring that promising technologies can transition from the laboratory to the marketplace effectively.
Case Study: Avelios Medical GmbH
Company Overview: Avelios Medical GmbH, based in Germany, is a pioneering company that has emerged as a winner of the EIC Accelerator in 2023. The company has developed a groundbreaking project titled "Digitising Hospitals For Better Patient Care," which represents a significant advancement in the healthcare industry.
Project Overview: The core of the project is the creation of the first modular, interconnected, data- and AI-driven software platform designed specifically for the digitization of patient care. This platform aims to streamline hospital operations, improve patient outcomes, and enhance the overall quality of healthcare services.
Technology Background
The technology behind Avelios Medical's platform is rooted in the convergence of data analytics, artificial intelligence, and modular software design. The platform allows hospitals to integrate various data sources, including electronic health records, patient management systems, and real-time monitoring devices. By consolidating this data, healthcare providers can gain insights into patient care processes, resource allocation, and operational efficiency.
Conclusion
The EIC Accelerator program represents a vital component of Europe's strategy to foster innovation and support high-potential startups and SMEs. Avelios Medical GmbH's project exemplifies how such funding can propel groundbreaking technologies in the healthcare sector, ultimately leading to improved patient care and operational efficiencies. As the EIC Accelerator continues to support innovative companies, it reinforces the significance of collaboration between public funding and private sector investment in driving technological advancements and economic growth within the European Union.
2 The Funding Rounds
Financing Raised by Avelios Medical GmbH Since EIC Accelerator Funding
EIC Accelerator Grant (2023)
- In August 2024, Avelios Medical announced it secured €2.5 million in non-dilutive grant funding from the European Innovation Council (EIC) Accelerator. The award was based on their successful application to the EIC cut-off dated January 11, 2023.
- The grant aimed to accelerate development of Avelios' hospital information system platform, particularly its workflow automation and AI-driven clinical decision support features.
Series A Funding Round (February 2025)
- In February 2025, Avelios Medical completed a significant Series A financing round, raising €30 million.
- This round was led by Sequoia Capital via its London office.
- Existing investors Revent and High-Tech Gründerfonds (HTGF), both active European venture capital funds with previous involvement in healthtech startups, also participated.
- The company did not publicly disclose its post-money valuation for this round. However, industry observers noted that the size of the Series A (€30M) is among the largest in Europe’s digital health sector recently.
Summary Table: Major Funding Rounds Since January 2023
| Date | Round | Amount Raised | Investors | Notes |
|---|---|---|---|---|
| Jan/Aug 2024 | EIC Grant | €2.5 million | European Innovation Council | Non-dilutive grant; supports product R&D |
| Feb 2025 | Series A | €30 million | Sequoia Capital (lead), Revent, HTGF | One of largest digital health Series As; valuation undisclosed |
Investor Information
Key Investors:
- Sequoia Capital: Led Series A; global VC with strong track record in healthcare and enterprise software.
- Revent: Early-stage investor focused on impact-driven technologies.
- High-Tech Gründerfonds (HTGF): German seed investor specializing in tech startups.
No information has been disclosed regarding additional individual angel investors or new institutional participants beyond those listed above as of May 2, 2025.
Company Valuations
Avelios Medical has not publicly disclosed its pre-money or post-money valuations for any funding rounds since winning the EIC Accelerator award. However:
Exit Events: IPOs or Acquisitions
As of May 2, 2025:
The company remains privately held and continues to expand within Germany while exploring further international growth opportunities.
Sources Avelios secures €30M led by Sequoia Capital for HIS HealthTech startup Avelios Medical secures €30 million Avelios nabs $31M led by Sequoia to fix healthcare IT - TechCrunch Germany-based Avelios Medical raises €30M led by Sequoia DORUCON secures funding for Avelios via EIC Accelerator - EU Commission Media Review
3 The Press Releases
Avelios Medical GmbH: A Pioneer in Healthcare Digitization
Avelios Medical GmbH, a cutting-edge health technology startup based in Munich, Germany, made significant strides in 2023. The company successfully secured funding from the European Innovation Council (EIC) Accelerator program during the January 2023 call, which closed on January 11, 2023.EIC Accelerator Funding
Avelios received €2.5 million in funding through the EIC Accelerator, thanks to the assistance of DORUCON, a management consultancy. This financial support is crucial for Avelios as it develops its innovative hospital data operating system.Technology Advancements
Avelios is pioneering a first-of-its-kind, modular, interconnected, data- and AI-driven software platform aimed at digitizing patient care in the healthcare industry. The platform includes comprehensive features such as electronic health records, medication management, operating room management, billing, staff management, and AI solutions. It is designed to tackle the challenge of outdated hospital information systems, which often lack interoperability and user-friendly interfaces.Team and Business Strategy
The company was founded by Dr. Sebastian Krammer, Nicolas Jakob, and Christian Albrecht, who recognized the need for modern, efficient hospital data systems during the COVID-19 pandemic. They took a bold approach by building a completely new hospital information system from scratch, focusing on modularity to facilitate phased implementation in hospitals.Recent Developments
In early 2025, Avelios raised €30 million in a Series B funding round led by Sequoia. This investment underscores the company's potential and momentum in the healthcare technology sector. Avelios has already secured contracts with several major hospitals in Germany, positioning it well for future growth.Press Releases and Updates
Avelios' achievements have been highlighted in various press releases and news articles. However, specific press releases on their website or social media accounts are not mentioned in available sources. The company's progress is often reported through external news outlets and funding announcements.Sources
- EIC Accelerator winners and statistics January 2023
- EIC Media Review - 14/04/2023
- Avelios raises €30M Series B for hospital data system overhaul
- DORUCON secures 2.5 million euros in EIC Accelerator for Avelios Medical
4 The Technology Advancements
Overview of Avelios Medical GmbH
Avelios Medical GmbH, based in Munich, Germany, is a medtech company founded in 2020. It specializes in developing innovative, modular software platforms for hospitals to digitize workflows and enhance patient care. The company's primary focus is on creating a modern, data-driven hospital information system (HIS) designed to streamline administrative tasks, reduce documentation burdens, and integrate AI-driven solutions for improved patient outcomes.
Advancements Since EIC Accelerator Funding
While specific details about advancements directly linked to the EIC Accelerator funding received on January 11, 2023, are not explicitly mentioned, Avelios Medical has made significant strides since then. Here are some key developments:
- Funding and Expansion: Avelios Medical secured €30 million in Series A funding led by Sequoia Capital in early 2025. This substantial investment highlights the company's growth and its potential to disrupt the healthcare IT landscape by providing a next-generation HIS.
- Technology and Features: Avelios' platform offers comprehensive digital documentation, including electronic health records (EHRs), medication management, and operating room administration. It also includes AI-driven solutions for clinical decision support and automated diagnostics. The modular architecture allows hospitals to implement the system flexibly, either step-by-step or as a full replacement.
- Market Demonstration: The company has successfully implemented its software in several prominent German hospitals, including the Ludwig-Maximilians-University Munich, Hannover Medical School, and Sana-Kliniken. This demonstrates the technology's effectiveness in real-world healthcare environments.
- Patents and Publications: There is no specific information available about new patents filed or scientific studies published by Avelios Medical directly linked to the EIC Accelerator funding. However, they have been involved in research collaborations, such as developing algorithms for skin lesion classification, indicating their ongoing commitment to innovation.
Conclusion
Avelios Medical continues to advance its technology and market presence, positioning itself as a leader in modernizing hospital information systems. With significant funding and strategic partnerships, the company is poised to further its mission of digitizing healthcare processes and enhancing patient care through AI-driven solutions.
Sources
- Avelios Medical: The modular & data-driven hospital platform
- Modular, Data-Driven, Connected, Avelios Medical Secures €30 Million from Sequoia Capital
- Germany's Top Startups | 2025
- Avelios nabs $31M led by Sequoia to fix the ailing world of healthcare IT
- Avelios raises €30M Series A led by Sequoia for hospital data system overhaul
- News & updates about Avelios
- HealthTech startup Avelios Medical secures €30 million to modernize hospital IT systems
- EHR News Round-Up – February 2025
- Avelios Medical Secures €30M Series A to Advance AI-Driven Solutions
- Avelios Medical secures 30 million euros for hospital information system
5 The Partnerships and Customers
Avelios Medical GmbH: Strategic Partnerships and Customer Growth Post-EIC Accelerator Funding Avelios Medical GmbH, a Munich-based healthtech company, has solidified its position as a next-generation hospital information system (HIS) provider through strategic partnerships and customer acquisitions. Following its €30 million Series A funding in early 2025 led by Sequoia Capital, the company is accelerating its mission to modernize healthcare IT systems across Europe.Key Customers
- Sana Kliniken: Germany’s largest private hospital chain with 56 facilities relies on Avelios’ HIS and patient portal for digitizing workflows.
- University Hospitals: Includes the Ludwig-Maximilians-University Munich Hospital and Hannover Medical School, which use Avelios’ platform for structured data management and AI-driven care.
Strategic Partnerships
- Sequoia Capital: The lead investor in its Series A round, providing capital to scale operations and enhance AI-driven innovations. Sequoia’s involvement underscores confidence in Avelios’ potential to replace legacy systems like SAP’s i.s.h.med.
- Revent & HTGF: Existing investors reinforcing commitment during the Series A round.
Market Positioning Through Relationships
The partnerships with leading hospitals and Sequoia position Avelios as a critical player in addressing the void left by SAP’s planned exit from the HIS market by 2030. By focusing on modular microservices architecture, Avelios enables hospitals to adopt tailored solutions while complying with stringent EU data security standards. These relationships also support AI integration—such as automated diagnostics—by leveraging structured patient data collected across workflows.Scaling Impact
Sequoia’s long-term investment strategy aligns with Avelios’ goal of sustainable innovation, allowing expansion into new European markets ahead of competitor shifts involving Dedalus and CompuGroup Medical. The company's customer base among large public/private hospitals provides real-world validation for broader adoption of its HIS platform, while technical advancements are driven by direct feedback from clinical users at partner institutions like LMU Hospital Munich.Sources
6 The Hiring and Company Growth
Avelios Medical GmbH: Team Growth and Development
Avelios Medical, a Munich-based healthtech startup, has been experiencing significant growth since receiving funding from the European Innovation Council Accelerator in 2023. Founded in 2020 by Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer, the company specializes in developing modern hospital information systems (HIS) to improve patient care through digitization and AI integration.
Current Headcount and Team Size
Avelios Medical does not publicly disclose its exact current headcount. However, the company has a team that includes a significant number of medical doctors and engineers. For instance, it has been mentioned that Avelios employs "a team of 11 medical doctors" alongside a strong engineering team.
Hiring and Team Growth
Avelios Medical is actively growing its team. The company has exciting open positions across various areas, indicating ongoing recruitment efforts. This growth is strategic, aiming to enhance its capabilities in delivering innovative healthcare solutions.
Recent Funding and Growth Impact
In early 2025, Avelios secured a €30 million Series A funding round led by Sequoia Capital, alongside existing investors Revent and High-Tech Gründerfonds (HTGF). This funding is instrumental in driving the development of its modular HIS system and expanding its market presence. The investment is a testament to the company's potential to revolutionize healthcare IT, particularly with SAP's upcoming exit from the healthcare sector, creating a significant market opportunity for Avelios.
Key Positions and Future Scaling
While specific recent hires are not detailed, Avelios's focus on engineering and medical expertise suggests that these areas are crucial for its growth. The addition of new team members will be pivotal in enhancing the company's technological capabilities and expanding its reach into more markets. For instance, Avelios is exploring opportunities in Spain, France, and the U.K..
Management and Founding Team
There have been no reported changes in the founding team or management structure. The co-founders, Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer, continue to lead the company with a strong vision for digital transformation in healthcare.
Impact on Future Growth
The new team members and investments will enable Avelios to scale its operations more effectively, providing modern, AI-driven hospital information systems that can replace outdated legacy systems. This strategic growth positions Avelios as a leading player in the healthcare IT sector, poised to capitalize on the opportunities arising from SAP's withdrawal and the broader push for healthcare digitization.
Sources
- A strong team with a clear mission | Avelios Medical
- Germany's Top Startups | 2025
- Munich's Avelios bags €30m to lead hospital IT systems
- Avelios Medical
- HealthTech startup Avelios Medical secures €30 million to modernise hospital IT systems
- Partnering with Avelios: Healthcare for the Modern Age
- Avelios nabs $31M led by Sequoia to fix the ailing world of healthcare IT
- Avelios Medical secures 30 million euros for hospital information system
7 The Media Features and Publications
Avelios Medical GmbH Overview
Avelios Medical GmbH is a Munich-based HealthTech startup focused on developing a modern hospital information system (HIS) to digitize workflows and enhance data-driven patient care. Founded in 2020 by Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer, the company aims to innovate healthcare by building an operating system for intelligent patient care.
Media Features and Publications
Avelios Medical has been featured in several publications following its successful funding rounds and innovative approach to healthcare technology. Notable mentions include:
- EU-Startups: Highlighted Avelios' €30 million Series A funding led by Sequoia Capital, emphasizing its goal to become the leading OS for intelligent patient care.
- Healthcare IT Today: Discussed Avelios' modular and data-driven hospital information system, noting its adoption by leading German hospitals.
- Tech.eu: Covered Avelios' funding and its modular approach to hospital data systems, highlighting its potential to fill the gap left by sunsetting HIS providers.
Content from Publications
Publications have praised Avelios' comprehensive hospital information system, which includes documentation, administration, patient portals, and AI solutions. The company's modular design allows for flexible implementation, catering to various hospital needs.
Podcasts and Interviews
Christian Albrecht, Co-Founder of Avelios Medical, participated in a podcast with Startup Insider, discussing the company's vision for healthcare transformation and its recent funding round.
Conference and Fair Visits
There is no specific information available regarding Avelios Medical's participation in conferences or fairs following their EIC Accelerator funding in January 2023. However, the company's focus on developing modern HIS solutions aligns with the need for innovation highlighted at healthcare conferences.
Event Involvement
Avelios Medical's involvement in events is likely to be centered around healthcare digitization and innovation, given its mission and recent funding. The company is poised to leverage events for showcasing its solutions and engaging with potential partners and clients.
Conclusion
Avelios Medical GmbH has made significant strides in the healthcare technology sector, particularly with its modern HIS and successful funding rounds. The company's media presence and event participation reflect its growing influence in the industry.
Sources: - Avelios Press
- EU-Startups: HealthTech startup Avelios Medical secures €30 million
- HitConsultant: German Startup Avelios Medical Raises $31.1M
- Healthcare IT Today: Modular, Data-Driven, Connected
- HTGF Investment Avelios Medical
- Startup Insider Podcast
- Tech.eu: Avelios raises €30M Series A led by Sequoia
Do you need EIC Accelerator support?
Here is a list of the key service options for the EIC Accelerator:
Full Writing Service
All proposal sections are written by Stephan Segler, PhD.
Advisory Service
You write in-house but receive 1-on-1 support, templates, instructions, and reviews of all documents.
AI Writer & Training
A high-quality AI writer for EIC Accelerator Step 1 and a comprehensive Training program for Steps 1 and 2 including all templates and instructions.